| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |